C-Telopeptide of Collagen

The C-Telopeptide of Collagen test, often called CTX, measures small fragments of type I collagen that are released into the bloodstream when bone is broken down. These fragments are known as C-terminal telopeptides and reflect the activity of bone resorption, the process by which old bone is removed.

Because bone is constantly being remodeled, CTX provides a snapshot of how actively your body is breaking down bone at the time of the blood draw. Levels can vary with time of day and recent food intake, so samples are commonly collected in the early morning before eating to improve consistency.

CTX helps your clinician understand your bone turnover status and is frequently used with bone density scans and other markers to evaluate conditions like osteoporosis. It is especially helpful for monitoring how well antiresorptive treatments, such as certain osteoporosis medications, are working over time and whether you are taking them as prescribed.

Doctors may also use CTX to look for unexpectedly high bone breakdown in situations like untreated thyroid or parathyroid disorders, prolonged immobility, or after certain cancer treatments. The test involves a standard blood draw and carries minimal risk.

Higher CTX results generally suggest increased bone breakdown, while lower results suggest suppressed resorption. Your clinician will interpret your result in the context of your age, sex, medical history, medications, and other tests. Because CTX is method dependent and changes throughout the day, it is best to compare results from the same laboratory and at similar collection times.

For many people, especially those starting or changing osteoporosis therapy, the trend over time is more informative than a single value. If a result is unexpected, your clinician may repeat the test with standard preparation, review medications and supplements, and consider other causes such as changes in kidney function, recent fractures, illness, or major surgery.